VolitionRX (VNRX) has shared an announcement.
VolitionRx Limited is set for significant board changes as Dr. Martin Faulkes and Dr. Edward Futcher announced their retirement and decision not to stand for re-election at the upcoming Annual Meeting on July 2, 2024. Dr. Faulkes will also resign as Executive Chairman, while Dr. Futcher will leave his roles in the Nominations and Governance Committee and Audit Committee. Following the Annual Meeting, the Board will shrink from eight to six directors. Guy Innes is poised to become the interim Chairman and Chair of the Nominations and Governance Committee, provided he is re-elected. Additionally, the company has amended its Bylaws, lowering the quorum requirement for stockholder meetings from a majority to 33 1/3% of voting power.
For a thorough assessment of VNRX stock, go to TipRanks’ Stock Analysis page.
